Evidence map›Paper›PMID 33946908›Full record

ReviewInternational journal of molecular sciences2021

Synaptic Zinc: An Emerging Player in Parkinson's Disease.

Joanna Sikora, Abdel-Mouttalib Ouagazzal

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders.International journal of molecular sciences · 2025
    Review
  9. ZnJournal of the American Chemical Society · 2025
    Article
  10. Quantitative Control of ZnAnalytical chemistry · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Zinc Toxicity: Understanding the Limits.Molecules (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joanna SikoraCNRS, Laboratoire de Neurosciences Cognitives, (UMR 729), Aix Marseille Université, 13331 Marseille, France.
Abdel-Mouttalib OuagazzalCNRS, Laboratoire de Neurosciences Cognitives, (UMR 729), Aix Marseille Université, 13331 Marseille, France.
Centre National de la Recherche Scientifique · FRLaboratoire de Neurosciences Cognitives · FR

Funding

Association France Parkinson 145629Fondation de France 00070958
6 · The paper itself

Abstract

Alterations of zinc homeostasis have long been implicated in Parkinson's disease (PD). Zinc plays a complex role as both deficiency and excess of intracellular zinc levels have been incriminated in the pathophysiology of the disease. Besides its role in multiple cellular functions, Zn

Indexed as

AnimalsBasal GangliaCation Transport ProteinsCerebral CortexChelating AgentsCorpus StriatumFemaleHomeostasisHumansIntracellular FluidMaleMiceMice, KnockoutNerve DegenerationOxidopamineParkinson DiseaseCation Transport ProteinsChelating AgentsOxidopamineReceptors, N-Methyl-D-AspartateSlc30a3 protein, mouseZincmicemotor behaviorNMDA receptorsParkinson’s diseasestriatumsynaptic zinc

Identifiers

PMID33946908
PMCPMC8125092
OpenAlexW3159816986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.